Biosimilars of Monoclonal Antibody Market Report

Global and Region Biosimilars of Monoclonal Antibody Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：154
  • REPORT CODE：GMM913070
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Biosimilars of Monoclonal Antibody market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biosimilars of Monoclonal Antibodymarket, defines the market attractiveness level of Biosimilars of Monoclonal Antibody market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biosimilars of Monoclonal Antibody industry, describes the types of Biosimilars of Monoclonal Antibody market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biosimilars of Monoclonal Antibody market and the development prospects and opportunities of Biosimilars of Monoclonal Antibody industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biosimilars of Monoclonal Antibody market in Chapter 13.

    By Player:

    • Eli Lilly

    • Bayer

    • Amgen

    • Sanofi-Aventis

    • Merck

    • Novo Nordisk

    • GSK

    • BMS

    • Pfizer

    • Johnson & Johnson

    • Roche

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By End-User:

    • Application 1

    • Application 2

    • Application 3

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biosimilars of Monoclonal Antibody Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biosimilars of Monoclonal Antibody Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biosimilars of Monoclonal Antibody Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biosimilars of Monoclonal Antibody Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biosimilars of Monoclonal Antibody Market Analysis and Outlook to 2022

    • 7.1 Global Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    • 7.2 United States Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    • 7.3 Europe Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    • 7.4 China Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    • 7.5 Japan Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    • 7.6 India Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    • 7.7 South Korea Biosimilars of Monoclonal Antibody Consumption (2017-2022)

    8 Region and Country-wise Biosimilars of Monoclonal Antibody Market Analysis and Outlook to 2028

    • 8.1 Global Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    • 8.2 United States Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    • 8.3 Europe Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    • 8.4 China Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    • 8.5 Japan Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    • 8.6 India Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    • 8.7 South Korea Biosimilars of Monoclonal Antibody Consumption Forecast (2022-2028)

    9 Global Biosimilars of Monoclonal Antibody Market Outlook by Types and Applications to 2022

    • 9.1 Global Biosimilars of Monoclonal Antibody Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biosimilars of Monoclonal Antibody Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Application 1 Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Application 2 Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Application 3 Consumption and Growth Rate (2017-2022)

    10 Global Biosimilars of Monoclonal Antibody Market Outlook by Types and Applications to 2028

    • 10.1 Global Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biosimilars of Monoclonal Antibody Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biosimilars of Monoclonal Antibody Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biosimilars of Monoclonal Antibody Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biosimilars of Monoclonal Antibody Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biosimilars of Monoclonal Antibody Market Competitive Analysis

    • 14.1 Eli Lilly

      • 14.1.1 Eli Lilly Company Details

      • 14.1.2 Eli Lilly Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly Biosimilars of Monoclonal Antibody Product and Service

    • 14.2 Bayer

      • 14.2.1 Bayer Company Details

      • 14.2.2 Bayer Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer Biosimilars of Monoclonal Antibody Product and Service

    • 14.3 Amgen

      • 14.3.1 Amgen Company Details

      • 14.3.2 Amgen Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen Biosimilars of Monoclonal Antibody Product and Service

    • 14.4 Sanofi-Aventis

      • 14.4.1 Sanofi-Aventis Company Details

      • 14.4.2 Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Biosimilars of Monoclonal Antibody Product and Service

    • 14.6 Novo Nordisk

      • 14.6.1 Novo Nordisk Company Details

      • 14.6.2 Novo Nordisk Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novo Nordisk Biosimilars of Monoclonal Antibody Product and Service

    • 14.7 GSK

      • 14.7.1 GSK Company Details

      • 14.7.2 GSK Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GSK Biosimilars of Monoclonal Antibody Product and Service

    • 14.8 BMS

      • 14.8.1 BMS Company Details

      • 14.8.2 BMS Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BMS Biosimilars of Monoclonal Antibody Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Biosimilars of Monoclonal Antibody Product and Service

    • 14.10 Johnson & Johnson

      • 14.10.1 Johnson & Johnson Company Details

      • 14.10.2 Johnson & Johnson Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Product and Service

    • 14.11 Roche

      • 14.11.1 Roche Company Details

      • 14.11.2 Roche Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Roche Biosimilars of Monoclonal Antibody Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biosimilars of Monoclonal Antibody

    • Figure Biosimilars of Monoclonal Antibody Picture

    • Table Global Biosimilars of Monoclonal Antibody Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biosimilars of Monoclonal Antibody Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biosimilars of Monoclonal Antibody Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biosimilars of Monoclonal Antibody Consumption by Country (2017-2022)

    • Figure United States Biosimilars of Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Table Europe Biosimilars of Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Figure China Biosimilars of Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Figure Japan Biosimilars of Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Figure India Biosimilars of Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biosimilars of Monoclonal Antibody Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilars of Monoclonal Antibody Consumption Forecast by Country (2022-2028)

    • Figure United States Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biosimilars of Monoclonal Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Application 3 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Application 3 Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biosimilars of Monoclonal Antibody Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biosimilars of Monoclonal Antibody Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Biosimilars of Monoclonal Antibody Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Biosimilars of Monoclonal Antibody Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Biosimilars of Monoclonal Antibody Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Biosimilars of Monoclonal Antibody Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Biosimilars of Monoclonal Antibody Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Biosimilars of Monoclonal Antibody Product and Service

    • Table BMS (Foundation Year, Company Profile and etc.)

    • Table BMS Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table BMS Biosimilars of Monoclonal Antibody Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Biosimilars of Monoclonal Antibody Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Biosimilars of Monoclonal Antibody Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Biosimilars of Monoclonal Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Biosimilars of Monoclonal Antibody Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US